These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 24350808

  • 1. Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.
    Liu Q, Ma J, Strayer DR, Mitchell WM, Carter WA, Ma W, Richt JA.
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):165-9. PubMed ID: 24350808
    [Abstract] [Full Text] [Related]

  • 2. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population.
    Yen HL, McKimm-Breschkin JL, Choy KT, Wong DD, Cheung PP, Zhou J, Ng IH, Zhu H, Webby RJ, Guan Y, Webster RG, Peiris JS.
    mBio; 2013 Jul 16; 4(4):. PubMed ID: 23860768
    [Abstract] [Full Text] [Related]

  • 3. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts.
    Tang J, Zhang J, Zhou J, Zhu W, Yang L, Zou S, Wei H, Xin L, Huang W, Li X, Cheng Y, Wang D.
    Virol J; 2019 Jul 02; 16(1):87. PubMed ID: 31266524
    [Abstract] [Full Text] [Related]

  • 4. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
    Marjuki H, Mishin VP, Chesnokov AP, De La Cruz JA, Davis CT, Villanueva JM, Fry AM, Gubareva LV.
    J Virol; 2015 May 02; 89(10):5419-26. PubMed ID: 25740997
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. R229I substitution from oseltamivir induction in HA1 region significantly increased the fitness of a H7N9 virus bearing NA 292K.
    Tang J, Zou SM, Zhou JF, Gao RB, Xin L, Zeng XX, Huang WJ, Li XY, Cheng YH, Liu LQ, Xiao N, Wang DY.
    Emerg Microbes Infect; 2024 Dec 02; 13(1):2373314. PubMed ID: 38922326
    [Abstract] [Full Text] [Related]

  • 7. Characterization of substitutions in the neuraminidase of A(H7N9) influenza viruses selected following serial passage in the presence of different neuraminidase inhibitors.
    Farrukee R, Butler J, Reading PC, Hurt AC.
    Antiviral Res; 2019 Aug 02; 168():68-75. PubMed ID: 31132385
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
    Itoh Y, Shichinohe S, Nakayama M, Igarashi M, Ishii A, Ishigaki H, Ishida H, Kitagawa N, Sasamura T, Shiohara M, Doi M, Tsuchiya H, Nakamura S, Okamatsu M, Sakoda Y, Kida H, Ogasawara K.
    Antimicrob Agents Chemother; 2015 Aug 02; 59(8):4962-73. PubMed ID: 26055368
    [Abstract] [Full Text] [Related]

  • 10. R292K substitution and drug susceptibility of influenza A(H7N9) viruses.
    Sleeman K, Guo Z, Barnes J, Shaw M, Stevens J, Gubareva LV.
    Emerg Infect Dis; 2013 Aug 02; 19(9):1521-4. PubMed ID: 23965618
    [Abstract] [Full Text] [Related]

  • 11. PCR for detection of oseltamivir resistance mutation in influenza A(H7N9) virus.
    Wang W, Song Z, Guan W, Liu Y, Zhang X, Xu L, Li J, Yuan Z, Hu Y.
    Emerg Infect Dis; 2014 May 02; 20(5):847-9. PubMed ID: 24751348
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low replicative fitness of neuraminidase inhibitor-resistant H7N9 avian influenza a virus with R292K substitution in neuraminidase in cynomolgus macaques compared with I222T substitution.
    Suzuki S, Shichinohe S, Itoh Y, Nakayama M, Ishigaki H, Mori Y, Ogata-Nakahara A, Nguyen CT, Okamatsu M, Sakoda Y, Kida H, Ogasawara K.
    Antiviral Res; 2020 Jun 02; 178():104790. PubMed ID: 32272175
    [Abstract] [Full Text] [Related]

  • 18. Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation.
    He JY, Li C, Wu G.
    Drug Des Devel Ther; 2014 Jun 02; 8():2377-90. PubMed ID: 25489236
    [Abstract] [Full Text] [Related]

  • 19. Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.
    Woods CJ, Malaisree M, Long B, McIntosh-Smith S, Mulholland AJ.
    Sci Rep; 2013 Dec 20; 3():3561. PubMed ID: 24356381
    [Abstract] [Full Text] [Related]

  • 20. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T, Bahl J, Marathe BM, Culhane M, Stigger-Rosser E, Darnell D, Kaplan BS, Lowe JF, Webby RJ, Govorkova EA.
    Antiviral Res; 2015 May 20; 117():10-9. PubMed ID: 25701593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.